Med Biogene Stock Buy Hold or Sell Recommendation
| MBGNF Stock | USD 0.01 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Med BioGene is 'Not Rated'. Macroaxis provides Med BioGene buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MBGNF positions. The advice algorithm takes into account all of Med BioGene's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Med BioGene's buy or sell advice are summarized below:
Real Value 0.0 | Hype Value 0.0 | Market Value 0.01 | Naive Value 0.00988 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Med BioGene given historical horizon and risk tolerance towards Med BioGene. When Macroaxis issues a 'buy' or 'sell' recommendation for Med BioGene, the advice is generated through an automated system that utilizes algorithms and statistical models.
Med |
Execute Med BioGene Buy or Sell Advice
The Med recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Med BioGene. Macroaxis does not own or have any residual interests in Med BioGene or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Med BioGene's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Med BioGene Trading Alerts and Improvement Suggestions
| Med BioGene is way too risky over 90 days horizon | |
| Med BioGene has some characteristics of a very speculative penny stock | |
| Med BioGene appears to be risky and price may revert if volatility continues | |
| Med BioGene has high likelihood to experience some financial distress in the next 2 years | |
| The company has a current ratio of 0.55, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Med BioGene until it has trouble settling it off, either with new capital or with free cash flow. So, Med BioGene's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Med BioGene sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Med to invest in growth at high rates of return. When we think about Med BioGene's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (59.96 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Med BioGene has accumulated about 38.6 K in cash with (145.12 K) of positive cash flow from operations. | |
| Roughly 49.0% of the company outstanding shares are owned by corporate insiders |
Med BioGene Returns Distribution Density
The distribution of Med BioGene's historical returns is an attempt to chart the uncertainty of Med BioGene's future price movements. The chart of the probability distribution of Med BioGene daily returns describes the distribution of returns around its average expected value. We use Med BioGene price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Med BioGene returns is essential to provide solid investment advice for Med BioGene.
| Mean Return | 0.99 | Value At Risk | 0.00 | Potential Upside | 0.00 | Standard Deviation | 7.78 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Med BioGene historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Med BioGene Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Med BioGene or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Med BioGene's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Med pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.92 | |
β | Beta against NYSE Composite | 1.04 | |
σ | Overall volatility | 7.78 | |
Ir | Information ratio | 0.12 |
Med BioGene Volatility Alert
Med BioGene is displaying above-average volatility over the selected time horizon. Med BioGene is a penny stock. Although Med BioGene may be in fact a good investment, many penny pink sheets are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Med BioGene. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Med instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Med BioGene Fundamentals Vs Peers
Comparing Med BioGene's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Med BioGene's direct or indirect competition across all of the common fundamentals between Med BioGene and the related equities. This way, we can detect undervalued stocks with similar characteristics as Med BioGene or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Med BioGene's fundamental indicators could also be used in its relative valuation, which is a method of valuing Med BioGene by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Med BioGene to competition |
| Fundamentals | Med BioGene | Peer Average |
| Return On Asset | -2.48 | -0.14 |
| Current Valuation | 251.67 K | 16.62 B |
| Shares Outstanding | 17.26 M | 571.82 M |
| Shares Owned By Insiders | 48.71 % | 10.09 % |
| Price To Earning | (3.33) X | 28.72 X |
| EBITDA | (59.96 K) | 3.9 B |
| Net Income | (59.96 K) | 570.98 M |
| Cash And Equivalents | 38.6 K | 2.7 B |
| Current Ratio | 0.56 X | 2.16 X |
| Book Value Per Share | (0) X | 1.93 K |
| Cash Flow From Operations | (145.12 K) | 971.22 M |
| Earnings Per Share | (0) X | 3.12 X |
| Number Of Employees | 7 | 18.84 K |
| Beta | 0.15 | -0.15 |
| Market Capitalization | 1.83 M | 19.03 B |
| Total Asset | 10.79 K | 29.47 B |
| Z Score | -16.5 | 8.72 |
| Net Asset | 10.79 K |
Med BioGene Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Med . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Med BioGene Buy or Sell Advice
When is the right time to buy or sell Med BioGene? Buying financial instruments such as Med Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Med BioGene in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Money Market Funds Thematic Idea Now
Money Market Funds
Funds or Etfs investing in various types of short-term (less than one year) fixed income instruments of high-quality and liquidity. The Money Market Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Market Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Med BioGene Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Med Pink Sheet analysis
When running Med BioGene's price analysis, check to measure Med BioGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Med BioGene is operating at the current time. Most of Med BioGene's value examination focuses on studying past and present price action to predict the probability of Med BioGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Med BioGene's price. Additionally, you may evaluate how the addition of Med BioGene to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |